New Guidelines Upped Lung Cancer Screenings, But Gaps Remain

Follow Drugslib on

Medically reviewed by Drugs.com.

By Dennis Thompson HealthDay Reporter

MONDAY, March 24, 2025 -- More smokers are getting CT screenings for lung cancer, thanks to guideline changes that included younger people and those who’ve smoked less, a new study says.

However, significant gaps remain for these potentially life-saving scans, particularly among people with limited access to health care, researchers reported March 20 in JAMA Oncology.

“The updated guidelines substantially increased lung cancer screenings overall, even as cancer screenings declined during the COVID-19 pandemic," Tracy Crane, an associate professor of oncology at the University of Miami Miller School of Medicine, said in a news release.

"However, discrepancies for who is screened persist, underscoring the importance of addressing structural barriers in rural and underserved populations,” she added.

Lung cancer remains the leading cause of cancer death in the U.S. for both men and women, researchers said in background notes.

Since 2013, guidelines have recommended using low-dose CT chest scans to screen for lung cancer in older heavy smokers.

But those guidelines were updated in 2021 to start screening at 50 instead of 55, and to include those with a smoking history of 20 or more pack-years instead of 30 or more, researchers noted.

Pack-years are calculated by multiplying the number of years a person smoked by the number of packs they smoked each day.

To see whether these guideline changes brought in more patients, researchers analyzed data from more than 17,000 Americans who participated in a federal survey tracking U.S. health behaviors between 2019 and 2023.

Before the guideline change, only about 15% of people at high risk for lung cancer were up-to-date on their CT screenings, researchers found.

But a year after the guidelines were updated, the percentage jumped to 47% of those eligible for CT screening, results showed.

That’s better, but still less than half, researchers said. The numbers were lower in people without insurance, those without a primary care doctor and those in rural areas.

Lung cancer screenings require a referral, creating a barrier for people without a family doctor, researchers noted.

People who don’t get regular health care also might not be aware they’re eligible for such screening, researchers added.

CT screening can also be too pricey for people without insurance. Without coverage, a scan can cost hundreds of dollars, lead researcher LaShae Rolle, a doctoral research fellow at the University of Miami, noted in a news release.

People can access free or low-cost scans, “but screening is not a one-time deal. Patients should get a scan annually, and results may require additional testing," researcher Dr. Coral Olazagasti, an assistant professor of clinical medical oncology, said in a news release. "The costs come not only from the scan but the follow-up.”

Community outreach teams might be able to close these gaps, along with patient navigators who can help educate people and line up their screenings, researchers said.

"A person may say -- I don't have the money; I don't have insurance. But, no one thinks they have cancer," Rolle said. "I am a cancer survivor myself. I was diagnosed at 26. I understand how easy it is to brush off a screening, especially among those choosing between having food or getting screened.”

Rolle caught her breast cancer early and is now cancer-free.

"I would love for others to get screened so they can also catch cancer early, too," she said.

Sources

  • University of Miami, news release, March 20, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-03-25 00:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords